Several studies reported that RAD51 overexpression was associated with poor prognosis in various cancers such as non-small-cell lung carcinoma, head cancers, esophageal squamous cell carcinoma, breast cancer, melanoma, and CRC [19-24]. Here, RAD51 is linked to colorectal carcinoma.